Test Code FARV2 Nasopharyngeal- Respiratory Pathogen Panel with COVID-19, PCR (Filmarray)
Additional Codes
Epic: LAB15532
Specimen Required
Specimen Type: Nasopharyngeal Swab
Collection Container/Type
Preferred: Viral transport media (VTM)
Acceptable: Universal transport media (UTM)
Submission Container/Tube: VTM or UTM collection media
Specimen Volume: Swab
Collection Instructions:
- Nasopharyngeal Swab- Collect according to standard technique and immediately place swab into 3ml Viral transport media (VTM) or Universal transport media (UTM).
Specimen Stability
Room temperature: 4 hours
Refrigerated: 2 days
Frozen: Unacceptable
Reference Range
See laboratory report.
Rejection Due To
Specimen not received in appropriate transport container or at appropriate temperature.
Report Available
1-2 days
Method Name
Real-time, nested multiplexed polymerase chain reaction using the BioFire Respiratory Panel 2.1 (RP2.1)
Includes
Real-time, nested multiplexed polymerase chain reaction test designed to simultaneously identify nucleic acids from 22 different viruses and bacteria associated with respiratory tract infection from a single nasopharyngeal swab. Targets include: Adenovirus, Coronavirus 229E, Coronavirus HKU1, Coronavirus NL63, Coronavirus OC43, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Human Metapneumovirus, Human Rhinovirus/Enterovirus, Influenza A, Influenza B, Parainfluenza Virus 1, Parainfluenza Virus 2, Parainfluenza Virus 3, Parainfluenza Virus 4, Respiratory Syncytial Virus, Bordetella parapertussis, Bordetella pertussis, Chlamydia pneumoniae, Mycoplasma pneumoniae
Limitations
This assay cannot differentiate between Rhinovirus/Enterovirus.
If necessary for patient care, a positive result for
Rhinovirus/Enterovirus may be followed-up using an alternate
method. This assay should not be used if B. pertussis infection is
specifically suspected as it is less sensitive than other
alternatives. If suspected, ensure that B. pertussis specific
testing is ordered. Recent administration of a nasal influenza
vaccine may cause false positive results for Influenza A and/or
Influenza B.
Viral and bacterial nucleic acids may persist even though no viable
organism is present. Detection of nucleic acid does not imply that
the corresponding organisms are infectious or are the causative
agents of clinical symptoms. A negative result does not exclude the
possibility of viral or bacterial infection and should not be used
as the sole basis for patient management decisions. Assay
performance characteristics may vary with circulating strains and
this assay may not be able to distinguish between existing viral
strains and new variants as they emerge. Invalid results may be due
to inhibiting substances in the specimen and recollection should
occur.
Day(s) Performed
Daily